These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 847669)
1. [Treatment of parkinsonism]. Houeland T; Slettnes O; Sjaastad O Tidsskr Nor Laegeforen; 1977 Jan; 97(1):6-9. PubMed ID: 847669 [No Abstract] [Full Text] [Related]
2. [Treatment of parkinsonism]. Kaste M; Iivanainen M Duodecim; 1976; 92(10):514-25. PubMed ID: 949943 [No Abstract] [Full Text] [Related]
3. [Revision of the treatment strategy in Parkinson disease]. Staal-Schreinemachers AL; Wesseling H; Lakke JP Ned Tijdschr Geneeskd; 1986 May; 130(20):914-8. PubMed ID: 3724865 [No Abstract] [Full Text] [Related]
4. Drugs for parkinsonism. Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639 [No Abstract] [Full Text] [Related]
5. Electroretinographic changes in patients with parkinsonism treated with various classes of antiparkinsonian drugs. Filipová M; Balík J; Filip V; Rodný J; Krejcová H Act Nerv Super (Praha); 1979 Oct; 21(3):136-8. PubMed ID: 517077 [No Abstract] [Full Text] [Related]
6. [Antiparkinsonian drugs (author's transl)]. Ando K No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813 [No Abstract] [Full Text] [Related]
7. [Present-day treatment of parkinsonism in the aged]. Siegfried J Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539 [No Abstract] [Full Text] [Related]
8. Drug therapy for Parkinson's disease in the elderly. Robertson DR; George CF Br Med Bull; 1990 Jan; 46(1):124-46. PubMed ID: 2105818 [TBL] [Abstract][Full Text] [Related]
10. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism]. Presthus J Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985 [No Abstract] [Full Text] [Related]
12. Update on drug treatment of Parkinsonism. Winkelman AC Am Fam Physician; 1977 Jul; 16(1):118-20. PubMed ID: 18001 [No Abstract] [Full Text] [Related]
13. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease]. Dzudza M; Dzudza D Med Arh; 1974; 28(4):407-15. PubMed ID: 4613968 [No Abstract] [Full Text] [Related]
14. Considerations in the management of parkinsonism. Fahn S; Calne DB Neurology; 1978 Jan; 28(1):5-7. PubMed ID: 339124 [No Abstract] [Full Text] [Related]
15. The treatment of parkinsonism. Godwin-Austen R Practitioner; 1975 Oct; 215(1288):445-51. PubMed ID: 1202468 [No Abstract] [Full Text] [Related]
16. [Current status of antiparkinson therapy]. Pendefunda G Rev Med Chir Soc Med Nat Iasi; 1977; 81(1):151-6. PubMed ID: 866829 [No Abstract] [Full Text] [Related]
17. Pharmacological approaches to Parkinson's disease in the different phases of evolution. Giovannini P; Piccolo I; Scigliano G; Caraceni T J Neural Transm Suppl; 1986; 22():173-87. PubMed ID: 3097255 [TBL] [Abstract][Full Text] [Related]
18. [Clinical experiences with Nacom in the treatment of Parkinsonism]. Paal G Med Welt; 1978 Feb; 29(8):320-4. PubMed ID: 634126 [No Abstract] [Full Text] [Related]